ClinicalTrials.Veeva

Menu

Prediction of Kidney Injury After Hyperthermic Intraperitoneal Chemotherapy (HIPEC)* With Machine Learning

Y

Yonsei University Health System (YUHS)

Status

Completed

Conditions

Chemotherapy
Acute Kidney Injury

Treatments

Other: Data collection

Study type

Observational

Funder types

Other

Identifiers

NCT03895606
3-2019-0016

Details and patient eligibility

About

Patients undergoing cytoreductive surgery with hyperthermic intraoperative chemotherapy (CRS with HIPEC) are prone to postoperative kidney dysfunction. Previous models predicting kidney injury after CRS with HIPEC did not include intraoperative physiologic data. This study is designed to include not only mean arterial pressure but other parameters such as systolic, diastolic arterial pressure, heart rate, oxygen saturation, body temperature, cardiac index, stroke volume variation and many other physical parameters using a data collection system that can record them every 1-7 seconds. The data will be analyzed using machine learning algorithms.

Enrollment

57 patients

Sex

All

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients undergoing cytoreductive surgery with hyperthermic intraoperative chemotherapy

Exclusion criteria

  • patients under 19

Trial design

57 participants in 1 patient group

HIPEC
Description:
patients undergoing cytoreductive surgery and hyperthermic intraoperative chemotherapy due to carcinomatosis.
Treatment:
Other: Data collection

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems